Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trialThanyawee Puthanakit, Kiat Ruxrungtham, Vonthanak Saphonn et al.|The Lancet Infectious Diseases|2012Cited by 81
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trialIsabelle Andrieux‐Meyer, Shahnaz Murad, Muhammad Radzi Abu Hassan et al.|The Lancet. Gastroenterology & hepatology|2021Cited by 42
Response to planned treatment interruptions in HIV infection varies across childhoodDiana M. Gibb, Carlo Giaquinto, A Sarah Walker et al.|Zurich Open Repository and Archive (University of Zurich)|2010Cited by 34
Efficacy and Safety of Ravidasvir Plus Sofosbuvir in Chronic Hepatitis C Infected Subjects Without Cirrhosis or with Compensated Cirrhosis: Interim Analysis Results of a Two-Stage, Open-Label, Multicentre, Phase 2/3 TrialIsabelle Andrieux‐Meyer, Shahnaz Murad, Soek-Siam Tan et al.|SSRN Electronic Journal|2020Cited by 0